High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.9M
$1,936,290
Total Sells (Filtered)
$250K
$250,291
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-27 | $81,190 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-26 | $157,500 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-24 | $388,750 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-20 | $83,750 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-17 | $256,500 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-16 | $200,641 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
10% Owner
Discretionary Buy
|
2026-03-13 | $767,960 | P | Form 4 |
| TOI |
Oncology Institute, Inc.
|
Director
Discretionary Sell
|
2025-12-15 | $50,291 | S | Form 4 |
|
TOI
S
Oncology Institute, Inc.
Pacala Mark L
• Director
Discretionary SellΔOwn -21.0%
2025-11-18
$186,520
|
||||||
| TOI |
Oncology Institute, Inc.
|
Director
Discretionary SellΔOwn -21.0%
|
2025-11-18 | $186,520 | S | Form 4 |
| TOI |
Oncology Institute, Inc.
|
Director
Discretionary Sell
|
2025-11-18 | $4,840 | S | Form 4 |
| TOI |
Oncology Institute, Inc.
|
Director
Discretionary Sell
|
2025-11-18 | $8,640 | S | Form 4 |